Quetiapine as treatment for dopaminergic-induced dyskinesias in Parkinson's disease

被引：17

作者：

Baron, MS ^{[1
]}

Dalton, WB

机构：

[1] Hunter Holmes McGuire VA Med Ctr, SE Richmond PADRECC, Richmond, VA USA

[2] Emory Univ, Sch Med, Atlanta, GA USA

来源：

MOVEMENT DISORDERS | 2003年 / 18卷 / 10期

关键词：

D O I：

10.1002/mds.10551

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1208 / 1209

页数：2

共 17 条

[1] Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease [J].

Breier, A ;

Sutton, VK ;

Feldman, PD ;

Kadam, DL ;

Ferchland, I ;

Wright, P ;

Friedman, JH .

BIOLOGICAL PSYCHIATRY, 2002, 52 (05) :438-445

[2] Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease [J].

Dewey, RB ;

O'Suilleabhain, PE .

NEUROLOGY, 2000, 55 (11) :1753-1754

[3] Clozapine and risperidone treatment of psychosis in Parkinson's disease [J].

Ellis, T ;

Cudkowicz, ME ;

Sexton, PM ;

Growdon, JH .

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2000, 12 (03) :364-369

[4]

Fernandez HH, 2000, MOVEMENT DISORD, V15, P579, DOI 10.1002/1531-8257(200005)15:3<579::AID-MDS1024>3.0.CO

[5]

2-0

[6]

Fernandez HH, 1999, MOVEMENT DISORD, V14, P484, DOI 10.1002/1531-8257(199905)14:3<484::AID-MDS1016>3.0.CO

[7]

2-B

[8] Olanzapine and clozapine - Comparative effects on motor function in hallucinating PD patients [J].

Goetz, CG ;

Blasucci, LM ;

Leurgans, S ;

Pappert, EJ .

NEUROLOGY, 2000, 55 (06) :789-794

[9] PARKINSONISM - ONSET PROGRESSION AND MORTALITY [J].

HOEHN, MM ;

YAHR, MD .

NEUROLOGY, 1967, 17 (05) :427-&

[10]

Kapur S, 2000, J PSYCHIATR NEUROSCI, V25, P161

← 1 2 →